Ajanta Pharma Ltd. (AJANTPHARM) - Financials, balance sheet (quarterly)

2,554 INR

43.2

1.72%

Last update Jun 2, 3:29 PM IST

Main market

Day range

2,554

2,506.89990

2,561

Previous close

2,510.80005

Open

2,520

Access this stock data via API

Ajanta Pharma Ltd.

2,554.00

43.20

1.72%

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Sep 2023
Total assets	50.1B	47.9B	46.4B	44.3B
Current assets	28.4B	27.9B	27.3B	25.6B
Cash	—	—	1.3B	—
Cash equivalents	—	—	0	—
Cash and cash equivalents	1.8B	638.9M	1.3B	2.6B
Other short term investments	4.4B	6.9B	3.3B	2.2B
Accounts receivable	11.8B	10.2B	12.5B	11.4B
Other receivables	25.4M	202M	233.4M	225.4M
Inventory	9.0B	8.5B	8.3B	7.9B
Prepaid assets	—	—	959.3M	—
Restricted cash	—	—	12.8M	—
Assets held for sale	133.3M	88.5M	88.5M	0
Hedging assets	—	—	124.8M	—
Other current assets	1.2B	1.5B	1.3B	1.3B
Non current assets	21.7B	20.0B	19.1B	18.7B
Properties	17.2B	14.4B	14.6B	14.8B
Land and improvements	—	—	2.1B	—
Machinery furniture equipment	—	—	14.7B	—
Construction in progress	1.8B	3.5B	2.6B	2.0B
Leases	—	—	—	—
Accumulated depreciation	—	—	-8.8B	—
Goodwill	465.2M	133.2M	146.6M	90.6M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	465.2M	133.2M	146.6M	90.6M
Investments and advances	—	—	—	—
Other non current assets	127.1M	152.3M	94.4M	112.9M
Total liabilities	12.2B	11.1B	10.7B	9.5B
Current liabilities	10.0B	9.1B	9.0B	8.0B
Accounts payable	4.5B	4.2B	4.6B	3.6B
Accrued expenses	—	—	—	—
Short term debt	127M	112.5M	117.6M	105.5M
Deferred revenue	—	—	—	—
Tax payable	405.3M	552M	447.7M	815.2M
Pensions	—	—	177.6M	—
Other current liabilities	911.2M	607.7M	597.3M	251.5M
Non current liabilities	2.3B	2.0B	1.8B	1.5B
Long term provisions	802.7M	672.2M	395.4M	228.7M
Long term debt	347.2M	215.4M	235.2M	224.7M
Provision for risks and charges	—	—	13.7M	—
Deferred liabilities	1.1B	1.1B	1.1B	1.0B
Derivative product liabilities	—	—	—	—
Other non current liabilities	20M	21.7M	1.7M	25M
Shareholders equity
Common stock	250.7M	250.7M	252.7M	252.7M
Retained earnings	—	—	33.1B	—
Other shareholders equity	—	—	—	—
Total shareholders equity	37.9B	36.8B	35.7B	34.8B
Additional paid in capital	—	—	4.4M	—
Treasury stock	—	—	—	—
Minority interest	—	—	0	—